• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X 射线晶体学分析结合脂肪酸酰胺水解酶人源化变体的 alpha-酮杂环抑制剂。

X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.

机构信息

Department of Chemistry, The Skaggs Institute for Chemical Biology,The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

出版信息

J Med Chem. 2010 Jan 14;53(1):230-40. doi: 10.1021/jm9012196.

DOI:10.1021/jm9012196
PMID:19924997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2804032/
Abstract

Three cocrystal X-ray structures of the alpha-ketoheterocycle inhibitors 3-5 bound to a humanized variant of fatty acid amide hydrolase (FAAH) are disclosed and comparatively discussed alongside those of 1 (OL-135) and its isomer 2. These five X-ray structures systematically probe each of the three active site regions key to substrate or inhibitor binding: (1) the conformationally mobile acyl chain-binding pocket and membrane access channel responsible for fatty acid amide substrate and inhibitor acyl chain binding, (2) the atypical active site catalytic residues and surrounding oxyanion hole that covalently binds the core of the alpha-ketoheterocycle inhibitors captured as deprotonated hemiketals mimicking the tetrahedral intermediate of the enzyme-catalyzed reaction, and (3) the cytosolic port and its uniquely important imbedded ordered water molecules and a newly identified anion binding site. The detailed analysis of their key active site interactions and their implications on the interpretation of the available structure-activity relationships are discussed providing important insights for future design.

摘要

公开并比较了三种 α-酮杂环抑制剂 3-5 与人源化脂肪酸酰胺水解酶(FAAH)变体结合的共晶 X 射线结构,以及 1(OL-135)及其异构体 2 的结构。这五个 X 射线结构系统地探测了三个关键的活性位点区域中的每一个,这些区域对于底物或抑制剂结合至关重要:(1)构象灵活的酰基结合口袋和膜进入通道,负责脂肪酸酰胺底物和抑制剂酰基链结合,(2)非典型的活性位点催化残基和周围的氧阴离子穴,共价结合捕获的α-酮杂环抑制剂的核心,作为模拟酶催化反应的四面体中间物的去质子化半缩酮,以及(3)胞质腔及其独特的重要嵌入有序水分子和新鉴定的阴离子结合位点。讨论了它们关键的活性位点相互作用及其对现有结构-活性关系解释的影响,为未来的设计提供了重要的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/66c47226036b/nihms-160711-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/f0cb312636e0/nihms-160711-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/5f4193fd4025/nihms-160711-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/61ce70d8b22e/nihms-160711-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/62b06e0d39a4/nihms-160711-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/8b00ba7dd10d/nihms-160711-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/6bcf26fd4a0f/nihms-160711-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/0fe0d9a5ec56/nihms-160711-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/d429865b3d84/nihms-160711-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/c9366456ab54/nihms-160711-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/66c47226036b/nihms-160711-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/f0cb312636e0/nihms-160711-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/5f4193fd4025/nihms-160711-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/61ce70d8b22e/nihms-160711-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/62b06e0d39a4/nihms-160711-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/8b00ba7dd10d/nihms-160711-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/6bcf26fd4a0f/nihms-160711-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/0fe0d9a5ec56/nihms-160711-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/d429865b3d84/nihms-160711-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/c9366456ab54/nihms-160711-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7875/2804032/66c47226036b/nihms-160711-f0010.jpg

相似文献

1
X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.X 射线晶体学分析结合脂肪酸酰胺水解酶人源化变体的 alpha-酮杂环抑制剂。
J Med Chem. 2010 Jan 14;53(1):230-40. doi: 10.1021/jm9012196.
2
Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by alpha-ketoheterocycle inhibitors revealed from cocrystal structures.从共晶体结构揭示α-酮杂环抑制剂对人源化脂肪酸酰胺水解酶的结合及失活机制
J Am Chem Soc. 2009 Aug 5;131(30):10497-506. doi: 10.1021/ja902694n.
3
Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.氟化物介导的可逆共价酶抑制剂非共价结合态捕获:脂肪酸酰胺水解酶的一种非常有效的 α-酮杂环抑制剂的 X 射线晶体结构分析。
J Am Chem Soc. 2011 Mar 23;133(11):4092-100. doi: 10.1021/ja110877y. Epub 2011 Feb 28.
4
Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.通过与两个活性位点残基共价结合来作用的脂肪酸酰胺水解酶抑制剂的合理设计。
J Am Chem Soc. 2013 Apr 24;135(16):6289-99. doi: 10.1021/ja4014997. Epub 2013 Apr 12.
5
α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.脂肪酸酰胺水解酶的α-酮杂环抑制剂:酰基侧链构象限制的探索
Bioorg Med Chem. 2014 May 1;22(9):2763-70. doi: 10.1016/j.bmc.2014.03.013. Epub 2014 Mar 18.
6
Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.含有酰侧链附加构象限制的脂肪酸酰胺水解酶可逆竞争性α-酮杂环抑制剂:具有口服活性和长效的镇痛药。
J Med Chem. 2011 Apr 28;54(8):2805-22. doi: 10.1021/jm101597x. Epub 2011 Mar 23.
7
Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH.含极性头基的 2-酮恶唑型 FAAH 抑制剂的设计、合成与评价。
Bioorg Med Chem. 2012 Jan 15;20(2):1100-12. doi: 10.1016/j.bmc.2011.11.027. Epub 2011 Nov 28.
8
Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.脂肪酸酰胺水解酶的α-酮杂环抑制剂中心杂环的优化
J Med Chem. 2008 Aug 14;51(15):4392-403. doi: 10.1021/jm800136b. Epub 2008 Jul 16.
9
Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.α-酮杂环酶抑制剂基本取代基效应的探索:脂肪酸酰胺水解酶的强效和选择性抑制剂
Bioorg Med Chem Lett. 2008 Nov 15;18(22):5842-6. doi: 10.1016/j.bmcl.2008.06.084. Epub 2008 Jun 28.
10
Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.设计、合成并鉴定了同时靶向脂肪酸酰胺水解酶胞质腔 Cys269 位的 α-酮杂环化合物。
J Med Chem. 2014 Feb 13;57(3):1079-89. doi: 10.1021/jm401820q. Epub 2014 Jan 23.

引用本文的文献

1
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition.非共价、非竞争性 FAAH 抑制的分子基础。
Int J Mol Sci. 2022 Dec 7;23(24):15502. doi: 10.3390/ijms232415502.
2
N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.N-酰基吡唑:有效的、可调节的丝氨酸水解酶抑制剂。
Bioorg Med Chem. 2019 Apr 15;27(8):1693-1703. doi: 10.1016/j.bmc.2019.03.020. Epub 2019 Mar 11.
3
Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.发现一种强效、长效且中枢神经系统活性的脂肪酸酰胺水解酶抑制剂(BIA 10-2474)。
ChemMedChem. 2018 Oct 22;13(20):2177-2188. doi: 10.1002/cmdc.201800393. Epub 2018 Sep 11.
4
Asymmetric Synthesis of Gonytolide A: Strategic Use of an Aryl Halide Blocking Group for Oxidative Coupling.高诺托内酯 A 的不对称合成:芳基卤化物阻断基团在氧化偶联反应中的策略性应用。
J Am Chem Soc. 2018 May 9;140(18):5969-5975. doi: 10.1021/jacs.8b02535. Epub 2018 Apr 25.
5
The Difference a Single Atom Can Make: Synthesis and Design at the Chemistry-Biology Interface.单原子的差异:化学-生物学界面的合成与设计。
J Org Chem. 2017 Dec 1;82(23):11961-11980. doi: 10.1021/acs.joc.7b02088. Epub 2017 Oct 13.
6
The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.双脂肪酸酰胺水解酶(FAAH)/环氧化酶(COX)抑制的分子基础。
ChemMedChem. 2016 Jun 20;11(12):1252-8. doi: 10.1002/cmdc.201500507. Epub 2015 Nov 23.
7
Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets.脂肪酸酰胺水解酶催化中脂质选择的关键:结构灵活性、门控残基和多个结合口袋。
PLoS Comput Biol. 2015 Jun 25;11(6):e1004231. doi: 10.1371/journal.pcbi.1004231. eCollection 2015 Jun.
8
Discovery libraries targeting the major enzyme classes: the serine hydrolases.针对主要酶类的发现型文库:丝氨酸水解酶。
Bioorg Med Chem Lett. 2014 Aug 15;24(16):3807-13. doi: 10.1016/j.bmcl.2014.06.063. Epub 2014 Jun 27.
9
α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.脂肪酸酰胺水解酶的α-酮杂环抑制剂:酰基侧链构象限制的探索
Bioorg Med Chem. 2014 May 1;22(9):2763-70. doi: 10.1016/j.bmc.2014.03.013. Epub 2014 Mar 18.
10
Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.设计、合成并鉴定了同时靶向脂肪酸酰胺水解酶胞质腔 Cys269 位的 α-酮杂环化合物。
J Med Chem. 2014 Feb 13;57(3):1079-89. doi: 10.1021/jm401820q. Epub 2014 Jan 23.

本文引用的文献

1
Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders.脂肪酸酰胺水解酶作为治疗疼痛和中枢神经系统疾病的潜在治疗靶点。
Expert Opin Drug Discov. 2009 Jul;4(7):763-784. doi: 10.1517/17460440903018857.
2
Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by alpha-ketoheterocycle inhibitors revealed from cocrystal structures.从共晶体结构揭示α-酮杂环抑制剂对人源化脂肪酸酰胺水解酶的结合及失活机制
J Am Chem Soc. 2009 Aug 5;131(30):10497-506. doi: 10.1021/ja902694n.
3
Fatty acid amide hydrolase inhibitors. Surprising selectivity of chiral azetidine ureas.脂肪酸酰胺水解酶抑制剂。手性氮杂环丁烷脲的惊人选择性。
Bioorg Med Chem Lett. 2009 Aug 1;19(15):4241-4. doi: 10.1016/j.bmcl.2009.05.097. Epub 2009 May 29.
4
Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.内源性大麻素降解酶的阻断可减轻神经性疼痛。
J Pharmacol Exp Ther. 2009 Sep;330(3):902-10. doi: 10.1124/jpet.109.155465. Epub 2009 Jun 5.
5
Discovery and characterization of a highly selective FAAH inhibitor that reduces inflammatory pain.一种可减轻炎性疼痛的高选择性脂肪酸酰胺水解酶(FAAH)抑制剂的发现与特性研究
Chem Biol. 2009 Apr 24;16(4):411-20. doi: 10.1016/j.chembiol.2009.02.013.
6
Benzothiophene piperazine and piperidine urea inhibitors of fatty acid amide hydrolase (FAAH).脂肪酸酰胺水解酶(FAAH)的苯并噻吩哌嗪和哌啶脲抑制剂。
Bioorg Med Chem Lett. 2009 May 15;19(10):2865-9. doi: 10.1016/j.bmcl.2009.03.080. Epub 2009 Mar 24.
7
Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.内源性大麻素对急性变应性模型搔抓反应的调节作用:瘙痒症的一个新的潜在神经治疗靶点。
J Pharmacol Exp Ther. 2009 Apr;329(1):314-23. doi: 10.1124/jpet.108.150136. Epub 2009 Jan 23.
8
Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.4-(3-苯基-[1,2,4]噻二唑-5-基)-哌嗪-1-羧酸苯酰胺的生化及生物学特性,一种基于机制的脂肪酸酰胺水解酶抑制剂
Anesth Analg. 2009 Jan;108(1):316-29. doi: 10.1213/ane.0b013e31818c7cbd.
9
Synthesis and evaluation of benzothiazole-based analogues as novel, potent, and selective fatty acid amide hydrolase inhibitors.基于苯并噻唑的类似物作为新型、强效和选择性脂肪酸酰胺水解酶抑制剂的合成与评价
J Med Chem. 2009 Jan 8;52(1):170-80. doi: 10.1021/jm801042a.
10
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.脂肪酸酰胺水解酶(FAAH)抑制剂的发现与开发。
J Med Chem. 2008 Dec 11;51(23):7327-43. doi: 10.1021/jm800311k.